https://m2.mtmt.hu/ hun 2026-09-23 10:57 JournalArticle 35195932 VALIDATED true Megosztott utolsó szerzőség 0 false 2026-07-17T01:38:06.421+0000 2025-04-25T07:24:47.134+0000 2024-09-02T08:39:25.302+0000 true 10069305 Kondor Zóra /api/admin/10069305 Admin Kondor Zóra (SE_KK_Admin5_KZ, admin) true 2026-01-23T09:40:28.850+0000 2026-01-23T09:40:28.850+0000 2025-04-25T07:24:47.142+0000 true 10099440 Csernyik Rita /api/admin/10099440 Admin Csernyik Rita (MTMT központi admin) true Admin 10099440 /api/admin/10099440 Csernyik Rita (MTMT központi admin) Csernyik Rita true true 2025-04-25T06:19:56.289+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Armos, Richard true true /api/journal/10003252 REVIEWED INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 true false 10003252 false 10003252 true 1661-6596 1422-0067 Journal FOREIGN 25 17 9362 9362 21 2024 Genetic alterations are well known to be related to the pathogenesis and prognosis of papillary thyroid carcinoma (PTC). Some miRNA expression dysregulations have previously been described in the context of cancer development including thyroid carcinoma. In our study, we performed original molecular diagnostics on tissue samples related to our own patients. We aimed to identify all dysregulated miRNAs in potential association with PTC development via sequencing much higher numbers of control-matched PTC tissue samples and analyzing a wider variety of miRNA types than previous studies. We analyzed the expression levels of 2656 different human miRNAs in the context of 236 thyroid tissue samples (118 tumor and control pairs) related to anonymized PTC cases. Also, KEGG pathway enrichment analysis and GO framework analysis were used to establish the links between miRNA dysregulation and certain biological processes, pathways of signaling, molecular functions, and cellular components. A total of 30 significant differential miRNA expressions with at least ±1 log2 fold change were found related to PTC including, e.g., miR-551b, miR-146b, miR-221, miR-222, and miR-375, among others, being highly upregulated, as well as miR-873 and miR-204 being downregulated. In addition, we identified miRNA patterns in vast databases (KEGG and GO) closely similar to that of PTC including, e.g., miRNA patterns of prostate cancer, HTLV infection, HIF-1 signaling, cellular responses to growth factor stimulus and organic substance, and negative regulation of gene expression. We also found 352 potential associations between certain miRNA expressions and states of clinicopathological variables. Our findings—supported by the largest case number of original matched-control PTC–miRNA relation research—suggest a distinct miRNA expression profile in PTC that could contribute to a deeper understanding of the underlying molecular mechanisms promoting the pathogenesis of the disease. Moreover, significant miRNA expression deviations and their signaling pathways in PTC presented in our study may serve as potential biomarkers for PTC diagnosis and prognosis or even therapeutic targets in the future. Funding 2043452 /api/funding/2043452 (2020- 4.1.1.-TKP2020-MOLORKIV) false true Funding 2043453 /api/funding/2043453 (SE HUN-REN-TKI ENDOMOLPAT) false true Funding 2043454 /api/funding/2043454 (K128780) Támogató: Nemzeti Kutatás, Fejlesztés és Innovációs Iroda false true true true 2024 true true true false true false GOLD 2026-07-17 false http://www.mdpi.com/journal/ijms 9 0 9 8 1 9 9 9 8 9 9 8 8 8 1 0 9 8 9 8 0 0 0 Folyóiratcikk Journal Article 24 9 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2024 0 2 1 2 1 2025 0 4 4 4 4 2026 0 3 3 3 3 D1 false 10012016,10024099,10024031 false false false 2024-09-01T08:39:33.403+0000 Belgyógyászati és Onkológiai Klinika (SE / AOK / K); Bioinformatikai központ (ÁTE / ÁJI); HUN-REN-SE Endokrin Molekuláris Patológiai Kuta... (SE / AOK / K / BOK); Országos Onkológiai Intézet; Patológiai, Igazságügyi és Biztosítási Orvostan... (SE / AOK / I) 17 24 5 17 0 true 10099440 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 118791515 /api/authorship/118791515 Armos, Richard [Ármós, Richárd Levente (Belgyógyászat), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K); HUN-REN-SE Endokrin Molekuláris Patológiai Kuta... (SE / AOK / K / BOK) 1 0.059 true false false Author 10078506 /api/author/10078506 Ármós Richárd Levente (Belgyógyászat) Ármós Richárd Levente true true Armos Richard true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791516 /api/authorship/118791516 Bojtor, Bence [Bojtor, Bence (Endokrinológia), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K) 2 0.059 false false false Author 10094857 /api/author/10094857 Bojtor Bence (Endokrinológia) Bojtor Bence true true Bojtor Bence true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791517 /api/authorship/118791517 Papp, Marton [Papp, Márton (Bioinformatika, B...), szerző] Bioinformatikai központ (ÁTE / ÁJI) 3 0.05882353 false false false Author 10071890 /api/author/10071890 Papp Márton (Bioinformatika, Biostatisztika) Papp Márton true true Papp Marton true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791518 /api/authorship/118791518 Illyes, Ildiko [Illyés, Ildikó (patológia), szerző] Patológiai, Igazságügyi és Biztosítási Orvostan... (SE / AOK / I) 4 0.059 false false false Author 10063921 /api/author/10063921 Illyés Ildikó (patológia) Illyés Ildikó true 10063921 true Illyes Ildiko true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791519 /api/authorship/118791519 Lengyel, Balazs [Lengyel, Balázs Levente (Endokrinológia pa...), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K) 5 0.059 false false false Author 10097409 /api/author/10097409 Lengyel Balázs Levente (Endokrinológia pajzsmirigy betegségek genetikája) Lengyel Balázs Levente true true Lengyel Balazs true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791520 /api/authorship/118791520 Kiss, Andras [Kiss, András (Belgyógyászat), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K) 6 0.059 false false false Author 10074311 /api/author/10074311 Kiss András (Belgyógyászat) Kiss András true true Kiss Andras true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791521 /api/authorship/118791521 Szili, Balazs [Szili, Balázs (belgyógyászat, en...), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K) 7 0.059 false false false Author 10035852 /api/author/10035852 Szili Balázs (belgyógyászat, endokrinológia) Szili Balázs true 10035852 true Szili Balazs true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791522 /api/authorship/118791522 Tobias, Balint [Tóbiás, Bálint (molekuláris bioló...), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K); HUN-REN-SE Endokrin Molekuláris Patológiai Kuta... (SE / AOK / K / BOK) 8 0.059 false false false Author 10024698 /api/author/10024698 Tóbiás Bálint (molekuláris biológia, endokrinológia) Tóbiás Bálint true 10024698 true Tobias Balint true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791523 /api/authorship/118791523 Balla, Bernadett [Balla, Bernadett (oszteoporozis), szerző] HUN-REN-SE Endokrin Molekuláris Patológiai Kuta... (SE / AOK / K / BOK) 9 0.059 false false false Author 10024611 /api/author/10024611 Balla Bernadett (oszteoporozis) Balla Bernadett true 10024611 true Balla Bernadett true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791524 /api/authorship/118791524 Piko, Henriett [Pikó, Henriett (molekuláris biológia), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K) 10 0.059 false false false Author 10050709 /api/author/10050709 Pikó Henriett (molekuláris biológia) Pikó Henriett true 10050709 true Piko Henriett true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791525 /api/authorship/118791525 Illes, Anett [Illés, Anett (Molekuláris bioló...), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K) 11 0.059 false false false Author 10048349 /api/author/10048349 Illés Anett (Molekuláris biológia, Genetika) Illés Anett true 10048349 true Illes Anett true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791526 /api/authorship/118791526 Putz, Zsuzsanna [Putz, Zsuzsanna (Belgyógyászat, di...), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K); HUN-REN-SE Endokrin Molekuláris Patológiai Kuta... (SE / AOK / K / BOK) 12 0.059 false false false Author 10013989 /api/author/10013989 Putz Zsuzsanna (Belgyógyászat, diabetológia, klinikofarmakológia) Putz Zsuzsanna true 10013989 true Putz Zsuzsanna true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791527 /api/authorship/118791527 Kiss, Andras [Kiss, András (Pathológia, hepat...), szerző] Patológiai, Igazságügyi és Biztosítási Orvostan... (SE / AOK / I) 13 0.059 false false false Author 10000554 /api/author/10000554 Kiss András (Pathológia, hepatocarcinogenesis) Kiss András true 10000554 true Kiss Andras true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791528 /api/authorship/118791528 Toth, Erika [Tóth, Erika (patológia), szerző] Országos Onkológiai Intézet 14 0.05882353 false false false Author 10062288 /api/author/10062288 Tóth Erika (patológia) Tóth Erika true 10062288 true Toth Erika true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791529 /api/authorship/118791529 Takacs, Istvan [Takács, István (Endokrinológia), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K) 15 0.059 false false false Author 10024031 /api/author/10024031 Takács István (Endokrinológia) Takács István true 10024031 true Takacs Istvan true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791530 /api/authorship/118791530 Kosa, Janos P.** [Kósa, János (molekuláris biológia), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K); HUN-REN-SE Endokrin Molekuláris Patológiai Kuta... (SE / AOK / K / BOK) 16 0.059 false true false Author 10024099 /api/author/10024099 Kósa János (molekuláris biológia) Kósa János true 10024099 true Kosa Janos P. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 118791531 /api/authorship/118791531 Lakatos, Peter ✉ [Lakatos, Péter (Osteológia, endok...), szerző] Belgyógyászati és Onkológiai Klinika (SE / AOK / K); HUN-REN-SE Endokrin Molekuláris Patológiai Kuta... (SE / AOK / K / BOK) 17 0.059 false true true Author 10012016 /api/author/10012016 Lakatos Péter (Osteológia, endokrinológia, molekuláris biológia) Lakatos Péter true 10012016 true Lakatos Peter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 26989402 /api/publicationidentifier/26989402 DOI: 10.3390/ijms25179362 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.3390/ijms25179362 https://doi.org/10.3390/ijms25179362 false true PublicationIdentifier 27540268 /api/publicationidentifier/27540268 WoS: 001310964000001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001310964000001 https://www.webofscience.com/wos/woscc/full-record/001310964000001 false true PublicationIdentifier 27540267 /api/publicationidentifier/27540267 Scopus: 85203619711 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85203619711 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85203619711 false true PublicationIdentifier 27283723 /api/publicationidentifier/27283723 PubMed: 39273308 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 39273308 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39273308&dopt=Abstract false true Classification 12215 /api/classification/12215 Klinikai orvostan true true SjrRating 11489344 /api/sjrrating/11489344 sjr:D1 (2024) Scopus - Organic Chemistry INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 18 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1605 /api/classificationexternal/1605 Scopus - Organic Chemistry true 1605 true D1 DIRECT true true Reference 56928494 /api/reference/56928494 1. Bartel 2004: Review MicroRNAs: Genomics, Biogenesis, Mechanism, and Function ulation of hematopoietic lineage differentiation in mam-mals (Chen et al., 2004), and control of leaf and flower development in plants (Aukerman and Sakai)., Cell, 116, p. 281, DOI: 10.1016/S0092-8674(04)00045-5 1 10.1016/S0092-8674(04)00045-5 false true Reference 56928495 /api/reference/56928495 2. Ambros, V. (2024, January 01). miRNAs Found by Genomics and Reverse Genetics [Internet]. Available online: www.nature.com/nature. 2 false true Reference 56928496 /api/reference/56928496 3. Mazeh 2013: Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy., J. Surg. Res., 180, p. 216, DOI: 10.1016/j.jss.2012.04.051 3 10.1016/j.jss.2012.04.051 false true Reference 56928497 /api/reference/56928497 4. Rossing 2010: A simple procedure for routine RNA extraction and miRNA array analyses from a single thyroid in vivo fine needle aspirate., Scand. J. Clin. Lab. Investig., 70, p. 529, DOI: 10.3109/00365513.2010.522250 4 10.3109/00365513.2010.522250 false true Reference 56928498 /api/reference/56928498 5. Geropoulos 2022: Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review., In Vivo, 36, p. 1551, DOI: 10.21873/invivo.12866 5 10.21873/invivo.12866 false true Reference 56928499 /api/reference/56928499 6. Taheri 2020: The role of microRNAs in the pathogenesis of thyroid cancer., Non-Coding RNA Res., 5, p. 88, DOI: 10.1016/j.ncrna.2020.06.001 6 10.1016/j.ncrna.2020.06.001 false true Reference 56928500 /api/reference/56928500 7. Ruiz-Pozo, V.A., Cadena-Ullauri, S., Guevara-Ramírez, P., Paz-Cruz, E., Tamayo-Trujillo, R., and Zambrano, A.K. (2023). Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer. Front. Med., 10., DOI: 10.3389/fmed.2023.1139362 7 10.3389/fmed.2023.1139362 false true Reference 56928501 /api/reference/56928501 8. Sassi 2017: Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling., Nat. Commun., 8, p. 1614, DOI: 10.1038/s41467-017-01737-4 8 10.1038/s41467-017-01737-4 false true Reference 56928502 /api/reference/56928502 9. Reddy 2017: miR-21 is associated with fibrosis and right ventricular failure., JCI Insight, 2, p. e91625, DOI: 10.1172/jci.insight.91625 9 10.1172/jci.insight.91625 false true Reference 56928503 /api/reference/56928503 10. De Martinis, M., Ginaldi, L., Allegra, A., Sirufo, M.M., Pioggia, G., Tonacci, A., and Gangemi, S. (2020). The osteoporosis/microbiota linkage: The role of miRNA. Int. J. Mol. Sci., 21., DOI: 10.3390/ijms21238887 10 10.3390/ijms21238887 false true Reference 56928504 /api/reference/56928504 11. Ghaffari 2023: Association of MicroRNA-146a with Type 1 and 2 Diabetes and their Related Complications., J. Diabetes Res., 2023, p. 2587104, DOI: 10.1155/2023/2587104 11 10.1155/2023/2587104 false true Reference 56928505 /api/reference/56928505 12. Nielsen 2012: Circulating levels of MicroRNA from children with newly diagnosed type 1 diabetes and healthy controls: Evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression., Exp. Diabetes Res., 2012, p. 896362 12 false true Reference 56928506 /api/reference/56928506 13. Xie 2015: The multiple roles of microrna-223 in regulating bone metabolism., Molecules, 20, p. 19433, DOI: 10.3390/molecules201019433 13 10.3390/molecules201019433 false true Reference 56928507 /api/reference/56928507 14. Plotkin 2021: MicroRNAs and osteocytes., Bone, 150, p. 115994, DOI: 10.1016/j.bone.2021.115994 14 10.1016/j.bone.2021.115994 false true Reference 56928508 /api/reference/56928508 15. Li, M.P., Hu, Y.D., Hu, X.L., Zhang, Y.J., Yang, Y.L., Jiang, C., Tang, J., and Chen, X.P. (2016). MiRNAs and miRNA polymorphisms modify drug response. Int. J. Environ. Res. Public Health, 13., DOI: 10.3390/ijerph13111096 15 10.3390/ijerph13111096 false true Reference 56928509 /api/reference/56928509 16. Slack 2006: Oncomirs—MicroRNAs with a role in cancer., Nat. Rev. Cancer, 6, p. 259, DOI: 10.1038/nrc1840 16 10.1038/nrc1840 false true Reference 56928510 /api/reference/56928510 17. Othman 2016: Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis., PeerJ, 2016, p. e2119 17 false true Reference 56928511 /api/reference/56928511 18. Li 2013: MicroRNA expression profiles in differentiated thyroid cancer, a review., Int. J. Clin. Exp. Med., 6, p. 74 18 false true Reference 56928512 /api/reference/56928512 19. Le 2017: MiR-181a promotes growth of thyroid cancer cells by targeting tumor suppressor RB1., Eur. Rev. Med. Pharmacol. Sci., 21, p. 5638 19 false true Reference 56928513 /api/reference/56928513 20. Calin 2006: MicroRNA signatures in human cancers., Nat. Rev. Cancer, 6, p. 857, DOI: 10.1038/nrc1997 20 10.1038/nrc1997 false true Reference 56928514 /api/reference/56928514 21. Toraih, E.A., Fawzy, M.S., Hussein, M.H., El-Labban, M.M., Ruiz, E.M.L., Attia, A.A., Halat, S., Moroz, K., Errami, Y., and Zerfaoui, M. (2021). MicroRNA-based risk score for predicting tumor progression following radioactive iodine ablation in well-differentiated thyroid cancer patients: A propensity-score matched analysis. Cancers, 13., DOI: 10.3390/cancers13184649 21 10.3390/cancers13184649 false true Reference 56928515 /api/reference/56928515 22. Chen 2008: MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma., Mod. Pathol., 21, p. 1139, DOI: 10.1038/modpathol.2008.105 22 10.1038/modpathol.2008.105 false true Reference 56928516 /api/reference/56928516 23. Nikiforova 2008: MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility., J. Clin. Endocrinol. Metab., 93, p. 1600, DOI: 10.1210/jc.2007-2696 23 10.1210/jc.2007-2696 false true Reference 56928517 /api/reference/56928517 24. Cancer Genome Atlas Research Network (2014). Integrated Genomic Characterization of Papillary Thyroid Carcinoma. Cell, 159, 676–690. 24 false true Reference 56928518 /api/reference/56928518 25. Bertol, B.C., Massaro, J.D., Debortoli, G., Santos, A.L.P., de Araújo, J.N.G., Giorgenon, T.M.V., e Silva, M.C., de Figueiredo-Feitosa, N.L., Collares, C.V.A., and de Freitas, L.C.C. (2023). BRAF, TERT and HLA-G Status in the Papillary Thyroid Carcinoma: A Clinicopathological Association Study. Int. J. Mol. Sci., 24., DOI: 10.3390/ijms241512459 25 10.3390/ijms241512459 false true Reference 56928519 /api/reference/56928519 26. Yusof, A.M., Jamal, R., Muhammad, R., Suhaimi, S.N.A., Rose, I.M., Saidin, S., and Ab Mutalib, N.-S. (2018). Integrated characterization of MicroRNA and mRNA transcriptome in papillary thyroid carcinoma. Front. Endocrinol., 9., DOI: 10.3389/fendo.2018.00158 26 10.3389/fendo.2018.00158 false true Reference 56928520 /api/reference/56928520 27. Santiago 2020: Differential MicroRNA-Signatures in Thyroid Cancer Subtypes., J. Oncol., 2020, p. 2052396, DOI: 10.1155/2020/2052396 27 10.1155/2020/2052396 false true Reference 56928521 /api/reference/56928521 28. Ricarte-Filho, J.C., Casado-Medrano, V., Reichenberger, E., Spangler, Z., Scheerer, M., Isaza, A., Baran, J., Patel, T., MacFarland, S.P., and Brodeur, G.M. (2023). DICER1 RNase IIIb domain mutations trigger widespread miRNA dysregulation and MAPK activation in pediatric thyroid cancer. Front. Endocrinol., 14., DOI: 10.3389/fendo.2023.1083382 28 10.3389/fendo.2023.1083382 false true Reference 56928522 /api/reference/56928522 29. Pallante 2006: MicroRNA deregulation in human thyroid papillary carcinomas., Endocr. Relat. Cancer, 13, p. 497, DOI: 10.1677/erc.1.01209 29 10.1677/erc.1.01209 false true Reference 56928523 /api/reference/56928523 30. He 2005: The role of microRNA genes in papillary thyroid carcinoma., Proc. Natl. Acad. Sci. USA, 102, p. 19075, DOI: 10.1073/pnas.0509603102 30 10.1073/pnas.0509603102 false true Reference 56928524 /api/reference/56928524 31. Chou 2010: miR-146b is Highly Expressed in Adult Papillary Thyroid Carcinomas with High Risk Features Including Extrathyroidal Invasion and the BRAF V600E Mutation., Thyroid, 20, p. 489, DOI: 10.1089/thy.2009.0027 31 10.1089/thy.2009.0027 false true Reference 56928525 /api/reference/56928525 32. Hatmal 2018: MiRNA-221/222 in thyroid cancer: A meta-analysis., Clin. Chim. Acta, 484, p. 284, DOI: 10.1016/j.cca.2018.06.012 32 10.1016/j.cca.2018.06.012 false true Reference 56928526 /api/reference/56928526 33. Tinahones 2019: New molecular biomarkers in differentiated thyroid carcinoma: Impact of miR-146, miR-221 and miR-222 levels in the evolution of the disease., Clin. Endocrinol., 91, p. 187, DOI: 10.1111/cen.13972 33 10.1111/cen.13972 false true Reference 56928527 /api/reference/56928527 34. Chou 2013: Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma., J. Clin. Endocrinol. Metab., 98, p. E196, DOI: 10.1210/jc.2012-2666 34 10.1210/jc.2012-2666 false true Reference 56928528 /api/reference/56928528 35. Deng 2015: MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3., Cell. Physiol. Biochem., 35, p. 71, DOI: 10.1159/000369676 35 10.1159/000369676 false true Reference 56928529 /api/reference/56928529 36. Khan, R., Riaz, A., Abbasi, S.A., Sadaf, T., Baig, R.M., and Mansoor, Q. (2023). Identification of transcriptional level variations in microRNA-221 and microRNA-222 as alternate players in the thyroid cancer tumor microenvironment. Sci. Rep., 13., DOI: 10.1038/s41598-023-42941-1 36 10.1038/s41598-023-42941-1 false true Reference 56928530 /api/reference/56928530 37. Pishkari 2018: The role of microRNAs in different types of thyroid carcinoma: A comprehensive analysis to find new miRNA supplementary therapies., J. Endocrinol. Investig., 41, p. 269, DOI: 10.1007/s40618-017-0735-6 37 10.1007/s40618-017-0735-6 false true Reference 56928531 /api/reference/56928531 38. Liu 2015: MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma., Biochem. Biophys. Res. Commun., 457, p. 621, DOI: 10.1016/j.bbrc.2015.01.037 38 10.1016/j.bbrc.2015.01.037 false true Reference 56928532 /api/reference/56928532 39. Schwertheim 2009: Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma., Horm. Metab. Res., 41, p. 475, DOI: 10.1055/s-0029-1215593 39 10.1055/s-0029-1215593 false true Reference 56928533 /api/reference/56928533 40. Park, J.L., Kim, S.K., Jeon, S., Jung, C.K., and Kim, Y.S. (2021). Microrna profile for diagnostic and prognostic biomarkers in thyroid cancer. Cancers, 13., DOI: 10.3390/cancers13040632 40 10.3390/cancers13040632 false true Reference 56928534 /api/reference/56928534 41. Haugen 2016: 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer., Thyroid, 26, p. 1, DOI: 10.1089/thy.2015.0020 41 10.1089/thy.2015.0020 false true Reference 56928535 /api/reference/56928535 42. Kanehisa 2017: KEGG: New perspectives on genomes, pathways, diseases and drugs., Nucleic Acids Res., 45, p. D353, DOI: 10.1093/nar/gkw1092 42 10.1093/nar/gkw1092 false true Reference 56928536 /api/reference/56928536 43. (2024, January 01). KEGG Pathways. Available online: https://www.genome.jp/kegg/. 43 false true Reference 56928537 /api/reference/56928537 44. The Gene Ontology Consortium, A Aleksander, S., Balhoff, J., Carbon, S., Cherry, J.M., Drabkin, H.J., Ebert, D., Feuermann, M., Gaudet, P., and Harris, N.L. (2023). The Gene Ontology knowledgebase in 2023. Genetics, 224, iyad031., DOI: 10.1093/genetics/iyad031 44 10.1093/genetics/iyad031 false true Reference 56928538 /api/reference/56928538 45. Ashburner 2000: Gene Ontology: Tool for the unification of biology The Gene Ontology Consortium., Nat. Genet., 25, p. 25, DOI: 10.1038/75556 45 10.1038/75556 false true Reference 56928539 /api/reference/56928539 46. (2024, January 01). GeneOntology. Available online: https://geneontology.org/. 46 false true Reference 56928540 /api/reference/56928540 47. Abdullah 2019: Papillary thyroid cancer: Genetic alterations and molecular biomarker investigations., Int. J. Med. Sci., 16, p. 450, DOI: 10.7150/ijms.29935 47 10.7150/ijms.29935 false true Reference 56928541 /api/reference/56928541 48. Hu 2016: Candidate microRNAs as biomarkers of thyroid carcinoma: A systematic review, meta-analysis, and experimental validation., Cancer Med., 5, p. 2602, DOI: 10.1002/cam4.811 48 10.1002/cam4.811 false true Reference 56928542 /api/reference/56928542 49. Silaghi, C.A., Lozovanu, V., Silaghi, H., Georgescu, R.D., Pop, C., Dobrean, A., and Georgescu, C.E. (2020). The prognostic value of micrornas in thyroid cancers—A systematic review and meta-analysis. Cancers, 12., DOI: 10.3390/cancers12092608 49 10.3390/cancers12092608 false true Reference 56928543 /api/reference/56928543 50. Geraldo 2012: MicroRNA miR-146b-5p regulates signal transduction of TGF-Β by repressing SMAD4 in thyroid cancer., Oncogene, 31, p. 1910, DOI: 10.1038/onc.2011.381 50 10.1038/onc.2011.381 false true Reference 56928544 /api/reference/56928544 51. McLeod 2019: Contemporary debates in adult papillary thyroid cancer management., Endocr. Rev., 40, p. 1481, DOI: 10.1210/er.2019-00085 51 10.1210/er.2019-00085 false true Reference 56928545 /api/reference/56928545 52. Yip 2011: MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma., Ann. Surg. Oncol., 18, p. 2035, DOI: 10.1245/s10434-011-1733-0 52 10.1245/s10434-011-1733-0 false true Reference 56928546 /api/reference/56928546 53. Stojanović, S., Šelemetjev, S., Đorić, I., Miljuš, J.J., Tatić, S., Živaljević, V., and Denčić, T.I. (2023). BRAFV600E, BANCR, miR-203a-3p and miR-204-3p in Risk Stratification of PTC Patients. Biomedicines, 11., DOI: 10.3390/biomedicines11123338 53 10.3390/biomedicines11123338 false true Reference 56928547 /api/reference/56928547 54. Sheu 2009: Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma., Horm. Metab. Res., 41, p. 482, DOI: 10.1055/s-0029-1215558 54 10.1055/s-0029-1215558 false true Reference 56928548 /api/reference/56928548 55. Nixon 2017: Circulating thyroid cancer biomarkers: Current limitations and future prospects., Clin. Endocrinol., 87, p. 117, DOI: 10.1111/cen.13369 55 10.1111/cen.13369 false true Reference 56928549 /api/reference/56928549 56. Stokowy 2016: Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity., Endocrine, 54, p. 440, DOI: 10.1007/s12020-016-1021-7 56 10.1007/s12020-016-1021-7 false true Reference 56928550 /api/reference/56928550 57. Zang 2020: Mir-137-3p modulates the progression of prostate cancer by regulating the JNK3/EZH2 axis., Onco. Targets Ther., 13, p. 7921, DOI: 10.2147/OTT.S256161 57 10.2147/OTT.S256161 false true Reference 56928551 /api/reference/56928551 58. Mazurek, M., Mlak, R., Homa-Mlak, I., Powrózek, T., Brzozowska, A., Kwaśniewski, W., Opielak, G., and Małecka-Massalska, T. (2022). Low miR 511-5p Expression as a Potential Predictor of a Poor Nutritional Status in Head and Neck Cancer Patients Subjected to Intensity-Modulated Radiation Therapy. J. Clin. Med., 11., DOI: 10.3390/jcm11030805 58 10.3390/jcm11030805 false true Reference 56928552 /api/reference/56928552 59. Qiao 2021: Aberrant expression of five miRNAs in papillary thyroid carcinomas., J. Clin. Lab. Anal., 35, p. e23907, DOI: 10.1002/jcla.23907 59 10.1002/jcla.23907 false true Reference 56928553 /api/reference/56928553 60. Swierniak 2013: In-depth characterization of the MicroRNA transcriptome in normal thyroid and papillary thyroid carcinoma., J. Clin. Endocrinol. Metab., 98, p. E1401, DOI: 10.1210/jc.2013-1214 60 10.1210/jc.2013-1214 false true Reference 56928554 /api/reference/56928554 61. Ji 2021: Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression., Cancer Gene Ther., 28, p. 693, DOI: 10.1038/s41417-020-00252-x 61 10.1038/s41417-020-00252-x false true Reference 56928555 /api/reference/56928555 62. Bai 2019: Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer., Turk. J. Gastroenterol., 30, p. 415, DOI: 10.5152/tjg.2019.17875 62 10.5152/tjg.2019.17875 false true Reference 56928556 /api/reference/56928556 63. Kondrotienė, A., Daukša, A., Pamedytytė, D., Kazokaitė, M., Žvirblienė, A., Daukšienė, D., Simanavičienė, V., Klimaitė, R., Golubickaitė, I., and Stakaitis, R. (2021). Papillary thyroid carcinoma tissue mir-146b,-21,-221,-222,-181b expression in relation with clinicopathological features. Diagnostics, 11., DOI: 10.3390/diagnostics11030418 63 10.3390/diagnostics11030418 false true Reference 56928557 /api/reference/56928557 64. Zhang, T., Chen, Y., Lin, W., Zheng, J., Liu, Y., Zou, J., Cai, J., Chen, Y., Li, Z., and Chen, Y. (2021). Prognostic and Immune-Infiltrate Significance of miR-222-3p and Its Target Genes in Thyroid Cancer. Front. Genet., 12., DOI: 10.3389/fgene.2021.710412 64 10.3389/fgene.2021.710412 false true Reference 56928558 /api/reference/56928558 65. Granitto 2020: PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker., Cancer Cytopathol., 128, p. 177, DOI: 10.1002/cncy.22224 65 10.1002/cncy.22224 false true Reference 56928559 /api/reference/56928559 66. Martini, M., de Pascalis, I., D’alessandris, Q.G., Fiorentino, V., Pierconti, F., Marei, H.E.-S., Ricci-Vitiani, L., Pallini, R., and Larocca, L.M. (2018). VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. BMC Cancer, 18., DOI: 10.1186/s12885-018-4442-2 66 10.1186/s12885-018-4442-2 false true Reference 56928560 /api/reference/56928560 67. Papaioannou, M., Chorti, A.G., Chatzikyriakidou, A., Giannoulis, K., Bakkar, S., and Papavramidis, T.S. (2022). MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment. Front. Oncol., 11., DOI: 10.3389/fonc.2021.755097 67 10.3389/fonc.2021.755097 false true Reference 56928561 /api/reference/56928561 68. YLam 2005: Papillary Carcinoma of Thyroid: A 30-yr Clinicopathological Review of the Histological Variants., Endocr. Pathol., 16, p. 323, DOI: 10.1385/EP:16:4:323 68 10.1385/EP:16:4:323 false true Reference 56928562 /api/reference/56928562 69. Almukhtar 2022: Histopathological Types of Papillary Thyroid Carcinoma: Clinicopathologic Study., Open Access Maced. J. Med. Sci., 10, p. 79, DOI: 10.3889/oamjms.2022.8059 69 10.3889/oamjms.2022.8059 false true /api/publication/35195932 Armos Richard et al. MicroRNA Profiling in Papillary Thyroid Cancer. (2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 25 17<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10078506"><a href="/gui2/?type=authors&mode=browse&sel=10078506" target="_blank">Armos Richard (<span class="authorship-author-name">Ármós Richárd Levente</span> <span class="authorAux-mtmt"> Belgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/HUN-REN-SE Endokrin Molekuláris Patológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10094857"><a href="/gui2/?type=authors&mode=browse&sel=10094857" target="_blank">Bojtor Bence (<span class="authorship-author-name">Bojtor Bence</span> <span class="authorAux-mtmt"> Endokrinológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10071890"><a href="/gui2/?type=authors&mode=browse&sel=10071890" target="_blank">Papp Marton (<span class="authorship-author-name">Papp Márton</span> <span class="authorAux-mtmt"> Bioinformatika, Biostatisztika</span>) </a> </span> <span class="author-affil"><span title="Állatorvostudományi Egyetem">ÁTE</span>/<span title="Állattudományi és Járványvédelmi Intézet">ÁJI</span>/Bioinformatikai központ</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10063921"><a href="/gui2/?type=authors&mode=browse&sel=10063921" target="_blank">Illyes Ildiko (<span class="authorship-author-name">Illyés Ildikó</span> <span class="authorAux-mtmt"> patológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Patológiai, Igazságügyi és Biztosítási Orvostani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10097409"><a href="/gui2/?type=authors&mode=browse&sel=10097409" target="_blank">Lengyel Balazs (<span class="authorship-author-name">Lengyel Balázs Levente</span> <span class="authorAux-mtmt"> Endokrinológia pajzsmirigy betegségek genetikája</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10074311"><a href="/gui2/?type=authors&mode=browse&sel=10074311" target="_blank">Kiss Andras (<span class="authorship-author-name">Kiss András</span> <span class="authorAux-mtmt"> Belgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10035852"><a href="/gui2/?type=authors&mode=browse&sel=10035852" target="_blank">Szili Balazs (<span class="authorship-author-name">Szili Balázs</span> <span class="authorAux-mtmt"> belgyógyászat, endokrinológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10024698"><a href="/gui2/?type=authors&mode=browse&sel=10024698" target="_blank">Tobias Balint (<span class="authorship-author-name">Tóbiás Bálint</span> <span class="authorAux-mtmt"> molekuláris biológia, endokrinológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/HUN-REN-SE Endokrin Molekuláris Patológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10024611"><a href="/gui2/?type=authors&mode=browse&sel=10024611" target="_blank">Balla Bernadett (<span class="authorship-author-name">Balla Bernadett</span> <span class="authorAux-mtmt"> oszteoporozis</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/HUN-REN-SE Endokrin Molekuláris Patológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10050709"><a href="/gui2/?type=authors&mode=browse&sel=10050709" target="_blank">Piko Henriett (<span class="authorship-author-name">Pikó Henriett</span> <span class="authorAux-mtmt"> molekuláris biológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10048349"><a href="/gui2/?type=authors&mode=browse&sel=10048349" target="_blank">Illes Anett (<span class="authorship-author-name">Illés Anett</span> <span class="authorAux-mtmt"> Molekuláris biológia, Genetika</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10013989"><a href="/gui2/?type=authors&mode=browse&sel=10013989" target="_blank">Putz Zsuzsanna (<span class="authorship-author-name">Putz Zsuzsanna</span> <span class="authorAux-mtmt"> Belgyógyászat, diabetológia, klinikofarmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/HUN-REN-SE Endokrin Molekuláris Patológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10000554"><a href="/gui2/?type=authors&mode=browse&sel=10000554" target="_blank">Kiss Andras (<span class="authorship-author-name">Kiss András</span> <span class="authorAux-mtmt"> Pathológia, hepatocarcinogenesis</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Patológiai, Igazságügyi és Biztosítási Orvostani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10062288"><a href="/gui2/?type=authors&mode=browse&sel=10062288" target="_blank">Toth Erika (<span class="authorship-author-name">Tóth Erika</span> <span class="authorAux-mtmt"> patológia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10024031"><a href="/gui2/?type=authors&mode=browse&sel=10024031" target="_blank">Takacs Istvan (<span class="authorship-author-name">Takács István</span> <span class="authorAux-mtmt"> Endokrinológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10024099"><a href="/gui2/?type=authors&mode=browse&sel=10024099" target="_blank">Kosa Janos P.^** (<span class="authorship-author-name">Kósa János</span> <span class="authorAux-mtmt"> molekuláris biológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/HUN-REN-SE Endokrin Molekuláris Patológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10012016"><a href="/gui2/?type=authors&mode=browse&sel=10012016" target="_blank">Lakatos Peter ✉ (<span class="authorship-author-name">Lakatos Péter</span> <span class="authorAux-mtmt"> Osteológia, endokrinológia, molekuláris biológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/HUN-REN-SE Endokrin Molekuláris Patológiai Kutatócsoport</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;35195932" target="_blank">MicroRNA Profiling in Papillary Thyroid Cancer</a></div> <div> <span class="journal-title">INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1661-6596">1661-6596</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1422-0067">1422-0067</a>)</span>: <span class="journal-volume">25</span> <span class="journal-issue">17</span> <span class="page"> Paper 9362. 21 p. </span> <span class="year">(2024)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.3390/ijms25179362" target="_blank" href="https://doi.org/10.3390/ijms25179362"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001310964000001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001310964000001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85203619711" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85203619711"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="39273308" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39273308&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Organic Chemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Spectroscopy&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Computer Science Applications&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Inorganic Chemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Physical and Theoretical Chemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Catalysis&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Molecular Biology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 9</span> | Független: 8 | Függő: 1 | Nem jelölt: 0 | WoS jelölt: 9 | Scopus jelölt:&nbsp;8 | WoS/Scopus jelölt:&nbsp;9 | DOI jelölt:&nbsp;9 </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 35195932</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (2020- 4.1.1.-TKP2020-MOLORKIV), (SE HUN-REN-TKI ENDOMOLPAT), (K128780) Támogató: NKFIH </div> <div class="lastModified">Utolsó módosítás: 2025.04.25. 09:24 Csernyik Rita (MTMT központi admin) </div> <div class="lockedBy">Központi kezelésű 2025.04.25. 08:19 Csernyik Rita (MTMT központi admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Megosztott utolsó szerzőség</pre> </div></div>